| VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 28, 2012) - Response Biomedical Corporation (TSX:RBM)(OTCBB:RPBIF) today reported financial results for the year ending December 31, 2011. Financial results for the year ended 2011 Product sales of $9.0 million for the year ended December 31, 2011, compared to $6.8 million for the year ended December 31, 2010. Cardiovascular sales have increased to $7.3 million in 2011, compared to $6.0 million in 2010. An increase in sales to China was th...continued RBM:CA RPBIF Electronics Technology Electronics |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment